Entera Bio ENTX
NASDAQ ENTX
$3.22 -0.02 (-0.62%)
At close: Nov 11, 2026 · 4:00 PM EST

Entera Bio (ENTX) Return on Sales [ROS] (2019 - 2025)

Updated

Entera Bio's Return on Sales [ROS] was -27523.81% in Q4 2025, down 24673.81 percentage points from -2850.00% a year earlier and down 18759.29 percentage points from the prior quarter.

Analysis

Entera Bio (ENTX) Return on Sales [ROS] (2019 - 2025) Analysis & Trends

For FY2025, Return on Sales [ROS] at Entera Bio came in at -27450.00%, down 22154.42 percentage points from FY2024.

  • Return on Sales [ROS] shows a five-year change of -24390.27 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Sales [ROS] was -5295.58% in FY2024, -9714.18% in FY2022 (-7574.60 pp) and -2139.58% in FY2021 (+920.15 pp).
  • The Q4 2025 figure marks the lowest quarterly Return on Sales [ROS] since Q3 2023.
  • Compared with a year earlier, Return on Sales [ROS] has declined for three straight quarters, with an average year-over-year change of +15839.28 percentage points over the last five quarters.
  • The best year-over-year quarter for Return on Sales [ROS] over five years was Q3 2024 (a gain of 64207.14 percentage points); the worst was Q2 2023 (a drop of 40229.55 percentage points).
  • Per Business Quant data, ENTX's Return on Sales [ROS] in the three quarters before Q4 2025 was -8764.52% (Q3 2025), -6378.92% (Q2 2025) and -6102.38% (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Entera Bio 563.51 Mn 269.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -27,450.00%
Sep 30, 2025 -8,729.03%
Jun 30, 2025 -6,378.92%
Mar 31, 2025 -6,102.38%
Dec 31, 2024 -2,850.00%
Sep 30, 2024 -7,192.86%
Jun 30, 2024 -3,859.65%
Sep 30, 2023 -71,400.00%
Jun 30, 2023 -47,613.64%
Mar 31, 2023 -17,263.64%
Dec 31, 2022 -21,914.29%
Sep 30, 2022 -35,812.50%
Jun 30, 2022 -7,384.09%
Mar 31, 2022 -5,639.71%
Dec 31, 2021 -2,477.58%
Sep 30, 2021 -2,300.00%
Jun 30, 2021 -2,357.80%
Mar 31, 2021 -1,489.81%
Dec 31, 2020 -9,052.49%
Sep 30, 2020 4,832.00%
API Access

Entera Bio Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ENTX&period=max&api_key=YOUR_API_KEY